Vertigo News and Research

Latest Vertigo News and Research

EMA CHMP issues positive opinion for Baxter's IVIG therapy for multifocal motor neuropathy

EMA CHMP issues positive opinion for Baxter's IVIG therapy for multifocal motor neuropathy

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

Study shows direct link between cotton swab use and ruptured eardrum

Study shows direct link between cotton swab use and ruptured eardrum

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy

EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Endolymphatic sac shunt surgery improved hearing loss symptoms in flight attendant

Endolymphatic sac shunt surgery improved hearing loss symptoms in flight attendant

State court jury rules in favor of Merck in FOSAMAX trial

State court jury rules in favor of Merck in FOSAMAX trial

Early MRI in young adults associated with lower rate of stroke misdiagnosis

Early MRI in young adults associated with lower rate of stroke misdiagnosis

Zogenix receives 2011 DDP Industry Achievement Award for SUMAVEL DosePro

Zogenix receives 2011 DDP Industry Achievement Award for SUMAVEL DosePro

Adjunctive lacosamide reduces seizures and improves responder rates

Adjunctive lacosamide reduces seizures and improves responder rates

Zogenix's SUMAVEL DosePro Needle-free Delivery System wins 2010 Most Innovative Product award

Zogenix's SUMAVEL DosePro Needle-free Delivery System wins 2010 Most Innovative Product award

Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

Denmark grants marketing authorization for SUMAVEL DosePro Needle-Free Delivery System

Denmark grants marketing authorization for SUMAVEL DosePro Needle-Free Delivery System

Long-term phase 3 trial confirms safety of lubiprostone in Japanese patients with chronic idiopathic constipation

Long-term phase 3 trial confirms safety of lubiprostone in Japanese patients with chronic idiopathic constipation

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Merck wins third FOSAMAX bellwether trial

Merck wins third FOSAMAX bellwether trial